Log in to search using one of your social media accounts:

 

Medical societies expand collaboration on cardiac registry
The American Society of Nuclear Cardiology (ASNC) and the American Society...Read more on AuntMinnie.comRelated Reading: ASNC, SNMMI advise on cardiac sarcoidosis ASNC releases guidance on MPI in women ASE: Echo protocol finds kids' heart abnormalities Echo groups release guidance on aortic stenosis Echo groups release new stress echo guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 19, 2017 Category: Radiology Source Type: news

Regular Evaluation Improves Survival in Asymptomatic Severe AS Regular Evaluation Improves Survival in Asymptomatic Severe AS
Patients with asymptomatic severe aortic stenosis followed according to guideline recommendations were more likely to undergo early valve replacement and had improved survival and reduced hospitalization.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 18, 2017 Category: Radiology Tags: Cardiology News Source Type: news

Do You Listen to Heart Sounds? This May be Another Reason Why You Should.
I’m not sure about you, but when I went to school to become a paramedic (and a nurse for that matter), one thing I never really understood was heart sounds, or heart tones, depending on who taught you. My attempt at learning resorted to scouring textbooks, journals, online editorials, watching clips on YouTube and listening… lots of listening to sound bites from CDs. You know the ones, they come free when you buy a new stethoscope. Instead of turning to digital media, I should’ve been listening to the hearts of my patients. Hindsight is 20/20, especially in this case. All my self-guided education yielded...
Source: JEMS Patient Care - September 12, 2017 Category: Emergency Medicine Authors: Bruce Hoffman, MSN,BSN-RN, NR-P, CFRN Tags: Patient Care Cardiac & Resuscitation Source Type: news

Tall VTE Risk; Frequent Aortic Stenosis Checks;'Sweet Spot' for LVAD Volume
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 8, 2017 Category: Cardiology Source Type: news

Close Watch on Aortic Stenosis May Improve Outcomes
(MedPage Today) -- Single-center study supports guideline-based serial evaluations for asymptomatic patients (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 7, 2017 Category: Cardiology Source Type: news

Serial Echos Valuable in Patients with Asymptomatic Severe Aortic Stenosis (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM Patients with asymptomatic severe aortic stenosis who don't get regular evaluations are at increased risk for death and heart failure, according to a retrospective study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 7, 2017 Category: Primary Care Source Type: news

Not adhering to recommended exams for severe narrowing of the aortic valve associated with increased heart failure
(The JAMA Network Journals) Patients with asymptomatic severe aortic stenosis who did not follow recommended guidelines for regular exams had poorer survival and were more likely to be hospitalized for heart failure, according to a study published by JAMA Cardiology. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 6, 2017 Category: International Medicine & Public Health Source Type: news

Intervention for Aortic Stenosis: Frailty Matters Intervention for Aortic Stenosis: Frailty Matters
The FRAILTY-AVR study evaluated different frailty scales in predicting poor outcomes following TAVR and SAVR. What did we learn and how will it influence clinical practice?Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Nonagenarians'Good Candidates' for TAVI Surgery Nonagenarians'Good Candidates' for TAVI Surgery
Severe aortic-stenosis patients aged 90 years or older can be candidates for transcatheter aortic-valve implantation, with similar outcomes to those in younger patients, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 1, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Cardiopulmonary Exercise Testing Prognostic in Aortic Stenosis
Conservative strategy results in good prognosis if CPET does not indicate hemodynamic compromise (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 25, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Pulmonology, Geriatrics, Journal, Source Type: news

Next-gen Repositionable Self-expanding Catheter Safe for Severe Aortic Stenosis Next-gen Repositionable Self-expanding Catheter Safe for Severe Aortic Stenosis
The self-expanding, repositionable Evolut R transcatheter heart valve (THV) from Medtronic appears safe and effective for treating older patients with severe aortic stenosis, according to a company-funded observational study.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2017 Category: Consumer Health News Tags: News Source Type: news

Medtronic wins FDA nod, CE Mark for Avalus aortic valve
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union and FDA approval in the US for its Avalus pericardial aortic surgical valve designed to treat aortic valve disease. The Avalus is the Fridley, Minn.-based company’s next-gen pericardial surgical aortic valve, and features a supra-annular design to improve hemodynamic performance and limit central regurgitation. The valve also features interior-mounted leaflet and frame design for improved durability and a low-profile design with a streamlined valve holder and single, one-cut release for easier implantations, Medtronic said. “Medt...
Source: Mass Device - August 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Replacement Heart Valves Medtronic Source Type: news

Medtronic touts reduced costs, rehospitalizations in cryoballoon vs RF AF ablation trial analysis
Medtronic (NYSE:MDT) today released data from a health economic analysis from the Fire And Ice trial comparing its Arctic Front cryoballoon catheter to its ThermoCool radiofrequency ablation cath, touting that cryoballoon treatment could reduce costs and rehospitalizations when used to treat paroxysmal atrial fibrillation. Economic analysis results from the trial were published today in the Journal of the American Heart Association. Researchers analyzed data from the 769-patient trial, which Medtronic claims is the largest to compare cryoballoon ablation to point-by-point RF ablation for treating paroxysmal AF, o...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Medtronic Source Type: news

Medtronic wins CE Mark for CoreValve Evolut Pro
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for its CoreValve Evolut Pro transcatheter aortic heart valve, indicated for the treatment of severe aortic stenosis for symptomatic patients at intermediate, high or extreme risk for open heart surgery The CoreValve Evolut Pro features an outer wrap to add surface area contact between the valve and the native aortic annulus to increase valve sealing performance, Fridley, Minn.-based Medtronic said. “We are excited to introduce the next evolution of our Evolut TAVI platform to provide physicians in Europe with a comprehensive portfolio...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Regulatory/Compliance Replacement Heart Valves Medtronic Source Type: news

Experience Journal: A bereaved mother ’s lessons from the heart
Jessica Lindberg’s son Ethan was a brave heart warrior whose journey at Boston Children’s Hospital began before he was even born. At 20 weeks, they learned he had aortic stenosis and evolving hypoplastic left heart syndrome (HLHS). At 22 weeks Ethan was the 30th baby to have an in-utero procedure to open his aortic valve and relieve pressure in the left side of his heart. By the time Ethan was 2, he’d had four open-heart surgeries. He was also having feeding problems, developmental delays, and was struggling with executive functioning and spatial tasks. Like many other parents of children with congen...
Source: Thrive, Children's Hospital Boston - July 27, 2017 Category: Pediatrics Authors: Ellen Greenlaw Tags: Diseases & Conditions Our Patients’ Stories Cardiac Neurodevelopmental Program congenital heart defect Dr. Janice Ware Experience Journal Heart Center hypoplastic left heart syndrome Source Type: news

3D printing helps evaluate leaks after TAVR procedures
3D-printed phantoms of aortic root anatomy offer a noninvasive way to assess...Read more on AuntMinnie.comRelated Reading: Echo groups release guidance on aortic stenosis ACC: CT detects blood clots that reduce valve motion CT better than echo for aortic annulus before TAVR Study finds differences in CCTA plaque measurements Cutting-edge techniques transform practice of cardiac CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 26, 2017 Category: Radiology Source Type: news

Stress Echo Value Questioned for Asymptomatic Aortic Stenosis
Neither increase in mean pressure gradient, systolic pulmonary artery pressure predicted outcome (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 26, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Nursing, Pulmonology, Radiology, Journal, Source Type: news

Morristown Medical Center Randomizes First Patient in World to New...
Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment for Asymptomatic Severe Aortic Stenosis; Trial may change treatment paradigm, save heart muscle(PRWeb July 13, 2017)Read the full story at http://www.prweb.com/releases/2017/07/prweb14507855.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2017 Category: Pharmaceuticals Source Type: news

Study: TAVR, surgical AVR results similar at 2 years in intermediate risk patients
Transcatheter and surgical aortic valve procedures were shown to have similar outcomes at 2 years in severe aortic stenosis patients deemed to be at intermediate surgical risk, according to a recently published study. Data came from a 2-year follow up with patients in the Partner 2 trial, which aimed to explore the difference between the 2 procedures in intermediate risk patients. A total of 2,032 patients were examined in the trial, which was randomly divided into 2 cohorts, with the 1st receiving Edwards Lifesciences‘(NYSE:EW) Sapien XT and the 2nd receiving a surgical AVR procedure. At 2 years, both disease-s...
Source: Mass Device - July 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves Edwards Lifesciences Source Type: news

FDA Expands CoreValve TAVR Indication to Intermediate-Risk Patients FDA Expands CoreValve TAVR Indication to Intermediate-Risk Patients
The expanded indication to include treatment of patients with severe aortic stenosis at intermediate risk for surgery is based on the pivotal SURTAVI data reported this March.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 10, 2017 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

FDA Gives Approval to Medtronic's CoreValve for Use in Patients at Intermediate Risk for Surgical Valve Replacement
Based on results from the landmark SURTAVI Clinical Trial, presented at the American College of Cardiology Annual Meeting in March, and published in the New England Journal of Medicine, the FDA has approved the CoreValve TAVR self-expanding platform for use in patients with severe and symptomatic aortic stenosis who are at "intermediate" risk for surgical valve replacement, defined as mortality>= 3% at 30 days. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - July 10, 2017 Category: Cardiology Source Type: news

FDA clears Medtronic ’ s CoreValve Evolut TAVR in intermediate risk patients
Medtronic (NYSE:MDT) said today it won expanded FDA approval for its CoreValve Evolut transcather aortic valve replacement platform, now indicated for patients with symptomatic severe aortic stenosis who are at an intermediate risk for open heart surgery. The Fridley, Minn.-based company said that patients at intermediate risk for open-heart surgery have a mortality risk of greater than or equal to 3% at 30 days following the procedure. “Patients at intermediate risk for open-heart surgery account for a large portion of the severe aortic stenosis population. We are delighted to take the self-expanding CoreV...
Source: Mass Device - July 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Replacement Heart Valves Medtronic Source Type: news

7 medtech stories we missed this week: June 9, 2017
[Image from unsplash.com]From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks Taiwanese distro deal for CGuard InspireMD announced in a June 8 press release that it has signed a distribution deal with Lorion Enterprises. The deal will expand InspireMD’s global footprint and distribute its CGuard Embolic Prevention System (EPS) through the medical device distributor in Taiwan. 2. Active Implants launches NUsurface knee trial Active Implants announced...
Source: Mass Device - June 9, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Regulatory/Compliance 3m Acacia Research Corp. Active Implants Advanced Cooling Therapy Attune Medical Exactech Inc. HLT InspireMD MedTech Source Type: news

ASE: Echo protocol finds kids' heart abnormalities
A new echocardiography protocol can detect early functional abnormalities in...Read more on AuntMinnie.comRelated Reading: Digisonics readies upgrades for ASE 2017 Echo groups release guidance on aortic stenosis Echo groups release new stress echo guidelines ASE debuts new educational offerings ASE offers guide for childhood heart disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 2, 2017 Category: Radiology Source Type: news

TAVR in the Care of Older Persons With Aortic Stenosis TAVR in the Care of Older Persons With Aortic Stenosis
This article reviews current literature on the safety and feasibility of transcatheter aortic valve replacement in the elderly, focusing on frailty as an aid to prognosis and decision-making.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 2, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Robot hearts: medicine ’s new frontier
From bovine valves to electrical motors and 3-D printed hearts, cardiologists are forging ahead with technologies once dismissed as “crazy ideas”On a cold, bright January morning I walked south across Westminster Bridge to St Thomas ’ Hospital, an institution with a proud tradition of innovation: I was there to observe a procedure generally regarded as the greatest advance in cardiac surgery since the turn of the millennium – and one that can be performed without a surgeon.The patient was a man in his 80s with aortic stenosis, a narrowed valve which was restricting outflow from the left ventricle in...
Source: Guardian Unlimited Science - May 23, 2017 Category: Science Authors: Thomas Morris Tags: Science Health Society Heart attack Technology Engineering Source Type: news

High Risk of Clinical Events With Moderate Aortic Stenosis Plus LVSD High Risk of Clinical Events With Moderate Aortic Stenosis Plus LVSD
The combination of moderate aortic stenosis and left ventricular systolic dysfunction (LVSD) is associated with a high risk of heart failure hospitalization and death, researchers report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 12, 2017 Category: Radiology Tags: News Source Type: news

Princeton Baptist Medical Center offers new aortic procedure
Princeton Baptist Medical Center has performed the first surgery in the state using a new treatment for severe aortic stenosis. It's the first facility in the Southeast to offer the technology - a new transcatheter aortic valve replacement procedure with a self-expanding implant and advanced sealing. The newly FDA-approved CoreValve Evolut PRO TAVR is for symptomatic patients who are at high or extreme risk for open heart surgery. “One of our strongest areas of expertise is treating patients… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 18, 2017 Category: American Health Authors: Stephanie Rebman Source Type: news

Conscious sedation is a safe alternative to general anesthesia for heart valve procedure
FINDINGSUCLA scientists have found that conscious sedation — a type of anesthesia in which patients remain awake but are sleepy and pain-free — is a safe and viable option to general anesthesia for people undergoing a minimally invasive heart procedure called transcatheter aortic valve replacement.In the study, patients who underwent conscious sedation had a similar rate of adverse events to those who underwent anesthesia, but those who were given conscious sedation had shorter stays in the intensive care unit (30 versus 96 hours for those with general anesthesia) and shorter hospital stays (4.9 days versus 10....
Source: UCLA Newsroom: Health Sciences - April 11, 2017 Category: Universities & Medical Training Source Type: news

Echo groups release guidance on aortic stenosis
The European Association of Cardiovascular Imaging and the American Society...Read more on AuntMinnie.comRelated Reading: Echo groups release new stress echo guidelines ASE debuts new educational offerings ASE offers guide for childhood heart disease ASE elects new president ASE: Aortic flow rate predicts risk of heart failure (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 3, 2017 Category: Radiology Source Type: news

Medtronic Receives FDA Approval for CoreValve ™ Evolut™ Pro Transcatheter Valve with Advanced Sealing
Medtronic plc (NYSE:MDT) today announced FDA approval and U.S. launch of the CoreValve ™ Evolut™ PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at high or extreme risk for open heart surgery. The approval comes on the heels of new 30-day clinical data that was unveiled at the American College of Cardiology (ACC) 66th Annual Scientific Sessio n, which showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and excellent hemodynamics for the self-expanding valve. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 22, 2017 Category: Cardiology Source Type: news

Medtronic wins FDA nod for CoreValve Evolut Pro
Medtronic (NYSE:MDT) said today it won FDA approval for its CoreValve Evolut Pro transcatheter arortic heart valve replacement designed for treating severe aortic stensosis. The newly cleared, next-gen CoreValve Evolut Pro features an outer wrap to add surface area contact between the valve and the native aortic annulus to increase valve sealing performance, Fridley, Minn.-based Medtronic said. “Medtronic remains committed to working with interventional cardiologists and cardiac surgeons to deliver solutions that address patient needs with the safety and performance profile they expect from Medtronic. We are excited ...
Source: Mass Device - March 22, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Replacement Heart Valves Medtronic Source Type: news

Self-expanding TAVR as good as surgery in intermediate-risk patients
Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate risk patients with severe aortic stenosis, according to research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 17, 2017 Category: Science Source Type: news

Self-expanding TAVR as good as surgery in intermediate-risk patients
(American College of Cardiology) Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 66th Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2017 Category: Global & Universal Source Type: news

Sharing Mayo Clinic: Daughter?s persistence leads to life-threatening discovery
Morgan Burke spent years urging her father, Tony Burke, to make a doctor?s appointment. When Tony was 12 years old, he had open-heart surgery at Mayo Clinic to repair aortic stenosis. But as an adult, the 48-year-old avoided most medical care. ?I?m just that type. I don?t go to the doctor ever ? unless I?m [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 4, 2017 Category: Databases & Libraries Source Type: news

9 cardiology breakthroughs you need to know
[Image courtesy of Michela on Flickr, per Creative Commons 2.0 license]Cardiology breakthroughs couldn’t come soon enough because heart disease is the No. 1 killer of men and women in the U.S. About 610,000 Americans die of heart disease per year, and an additional 735,000 Americans suffer from a heart attack. The statistics terrify. About 610,000 Americans die of heart disease per year, and an additional 735,000 Americans suffer from a heart attack. High blood pressure, high cholesterol and smoking are some of the top risk factors for heart disease, and 47% of Americans have at least one of these risk factors, ...
Source: Mass Device - March 3, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Cardiovascular Diagnostics Research & Development Robotics American Heart Association aortic stenosis cardiology heart disease ICD MedTech Medtronic pacemakers Source Type: news

Aortic stenosis test for open heart surgery is inaccurate
[Image from the American Heart Association]An approved exercise test that determines whether people with aortic stenosis need open heart surgery has only 60% accuracy, according to a new study by the University of Leicester. Cycling on a stationary bike typically determines whether a person needs surgery. If the patient becomes breathless while cycling, it is typically recommended to have valve replacement therapy. Gerry McCann, professor of cardiac imaging and honorary consultant cardiologist at the University of Leicester Department of Cardiovascular Science, conducted the research and found that the exercise test is &ld...
Source: Mass Device - March 3, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Cardiovascular aortic stenosis MedTech University of Leicester Source Type: news

Intervention vs. Symptom-driven Management in Aortic Stenosis Intervention vs. Symptom-driven Management in Aortic Stenosis
How should asymptomatic patients with severe aortic stenosis be managed? Is early aortic valve replacement beneficial?Heart (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Analyst bearish on intermediate-risk TAVR uptake, but still sees market as positive
While transcatheter aortic valve replacement technologies are on target to becoming a $5 billion market by 2021, analysts believe the path to indications for intermediate risk patients may be slower than previously expected. The market has showed a “notable step down in projected TAVR volume growth” in a set of surveys from April 2016 to Jan 2017, according to Leerink Partner analyst Danielle Antalffy. After a discussion with 5 interventional cardiologists, Antalffy wrote in a letter to investors that they still considered TAVR to be “one of the more exciting new MedTech markets that will exceed $5B by 20...
Source: Mass Device - March 2, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular Replacement Heart Valves Source Type: news

Inaccurate heart test costing the NHS, says Gerry McCann
Professor Gerry McCann, a cardiologist from the University of Leicester, was behind research that found exercise testing for aortic stenosis has only a 60 per cent accuracy rate. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2017 Category: Consumer Health News Source Type: news

Controversial test could be leading to unnecessary open heart operations
(University of Leicester) A University of Leicester researcher leads an aortic stenosis study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2017 Category: Global & Universal Source Type: news

Iron and Calcification in Aortic Stenosis Iron and Calcification in Aortic Stenosis
This article explores the mechanisms by which iron, which may accumulate in the aortic valve by means of intraleaflet hemorrhages, might influence development of aortic valve stenosis.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AHN enrolling patients in comparative heart valve replacement study
Allegheny Health Network is one of 60 sites nationwide actively enrolling patients in a trial to compare the efficacy of nonsurgical valve replacement in healthier patients who require medical intervention. Transcatheter aortic valve repair (Tavr), a five-year old procedure used to treat patients with aortic stenosis, is often recommended for older patients deemed too risky for traditional aortic valve replacement. Dr. Stephen Bailey, director of the division of cardiac surgery at Allegheny General… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2017 Category: Biotechnology Authors: Lydia Nuzum Source Type: news

Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies
The new Evolut R 34 mm valve is approved for severe aortic stenosis patients who are at intermediate, high or extreme risk for surgery with an annulus size ranging from 26-30 mm. This large valve segment is estimated to account for approximately 20-25 percent of the eligible European TAVI patient population. Previously, some of these patients were unable to receive a TAVI due to the larger size of their native diseased aortic valve. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 17, 2017 Category: Cardiology Source Type: news

Hands On Product Reviews January 2017
Improved Manikin Control Graphical user interface changed the way we interact with computers. Since the introduction of the Macintosh in 1984, all computers have become more intuitive and require less knowledge of computer code for the everyday user. Continuing the trend of easy use, the new SimPad Plus from Laerdal has increased the processor speed, improved WiFi connectivity and added a Bluetooth connection to increase the number of manikins the SimPad Plus can control. Running scenarios with manikins or standardized patients remains intuitive and allows the instructor to be in the room or in a vehicle throughout the sim...
Source: JEMS Operations - December 30, 2016 Category: Emergency Medicine Authors: Fran Hildwine, BS, NREMT-P Tags: Columns Equipment & Gear Source Type: news

Medtronic Announces Reimbursement Approval and Launch of CoreValve ™ Evolut™ R System in Japan
Medtronic plc (NYSE: MDT) today announced it has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the recapturable, self-expanding transcatheter CoreValve ™ Evolut™ R System for patients with severe aortic stenosis (AS) unable to undergo surgery, and for whom treatment with transcatheter aortic valve implantation (TAVI) is determined to be the best option. This approval follows the Shonin approval from the MHLW the company received in November.U (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - December 1, 2016 Category: Cardiology Source Type: news

For Aortic Stenosis, TAVR Shows Short-term QoL Benefit For Aortic Stenosis, TAVR Shows Short-term QoL Benefit
Quality-of-life scores improved over 1 month for TAVR patients, but only with transfemoral access, not transthoracic; but surgical-valve replacement patients caught up after a year.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 7, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Innovation seen in transcatheter aortic valve replacement
Great strides are being made in the treatment of heart disease with innovative new treatment options for valvular heart disease. Since 2007, I’ve had the privilege of serving on a team of Emory physicians that has helped revolutionize the treatment of severe aortic stenosis, leading the national effort to study and advance a new nonsurgical procedure called transcatheter aortic valve replacement or TAVR. Aortic stenosis is a dangerous heart condition that affects tens of thousands of Americans… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 31, 2016 Category: Pharmaceuticals Authors: Vinod Thourani Source Type: news

Edwards Lifesciences wins CE Mark for Inspiris Resilia aortic valve
Edwards Lifesciences (NYSE:EW) said today it won CE Mark approval in the European Union for its Inspiris Resilia aortic valve. The Irvine, Calif.-based company said the valve is the 1st in a “new class of resilient heart valves” which incorporate its Resilia tissue and features a Perimount Magna ease valve and VFit technology for future valve-in-valve procedures. “The Inspiris valve creates a new class of surgical valves and includes key patient-focused innovations, such as the resilient tissue and the VFit technology, to advance the treatment of patients with heart valve disease. In partnership with...
Source: Mass Device - September 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Regulatory/Compliance Edwards Lifesciences Source Type: news

Claret Medical files for FDA clearance for Sentinel cerebral protection device
Claret Medical said today that it filed an application with the FDA seeking 510(k) clearance for its Sentinel cerebral protection system designed for use during transcatheter aortic valve replacements. The Santa Rosa, Calif.-based company’s Sentinel device is designed to capture and remove embolic debris dislodged during TAVR procedures, which can enter cerebral circulation and can potentially lead to strokes. “Our contribution in building significant new science will help the rapidly growing TAVR field embrace the critical role of cerebral protection in all left heart and endovascular procedures. The...
Source: Mass Device - September 20, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Replacement Heart Valves Vascular Claret Medical Inc. Stroke Source Type: news